𝗥𝗲𝗺𝗶𝗻𝗱𝗲𝗿! Bench2Market Talks on 𝗡𝗼𝘃 𝟭𝟵, 𝟭𝟮–𝟭 𝗣𝗠 𝗘𝗧: European vs US Healthcare Markets & How to Break into Them Why are EU costs lower but innovation slower? Find out! ✅ Register: https://t.co/Uq3ygW87ud #MedTech #HealthcareInnovation

𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗢𝗣𝗘𝗡! Biolocity is looking for innovators in healthcare & life sciences. Know someone with a game-changing idea? Share this with them! 𝗔𝗽𝗽𝗹𝘆 𝗻𝗼𝘄: https://t.co/pVL0x6qy7x #Biolocity #Innovation #Healthcare

Why are European healthcare costs lower but innovation slower? Join Bench2Market Talks on 𝗡𝗼𝘃 𝟭𝟵, 𝟭𝟮–𝟭 𝗣𝗠, for insights on cultural contrasts & breaking into transatlantic markets. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄! https://t.co/Uq3ygW87ud #HealthcareInnovation #MedTech

Biolocity is accepting applications for the 2026–2027 cycle. If you're developing innovative medical technology, apply now for funding and support. Apply Here: http://biolocity.gatech/get-started/biolocity-application/  #Biolocity #MedTech #Innovation #FundingOpportunity

This Wednesday, Biolocity presents Bench2Market Talk featuring R&D Expert Jason Glithero! It's not too late to register. 📅Wed, Oct 22nd at 12pm EST 📍Zoom Register: https://t.co/yY0aY6cabR More Info: https://t.co/XrXSsR3Kbr Questions: email biolocity@gatech.edu

In case you missed it, B2M Talk: Securing Investment For Your Startup - Part 2 is now live on YouTube! Thank you @Portalinno and @_M_Schultz_ for sharing insights on the current investment landscape and strategy with the Biolocity community, and beyond. https://t.co/fwoEwSO9Lh

It's not too late to learn how to attract the right investors from Michael Schultz, PhD of @portalinno. Secure your spot now! 📅Wed, Sept 17th 🕛12:00 PM ET 📍Zoom Register: https://t.co/THFvbNUUwI More Info: https://t.co/QwqIl8FVfq

Join Michael Schultz for insights on raising capital & investor impact on strategy at Bench2Market Talk: Securing Investment For Your Startup - Part 2 of 3. 📅 Wednesday, September 17 🕒 12PM EST 📍Zoom 🔗 Learn more: https://t.co/TXy3wELbf5 👉 Register: https://t.co/THFvbNUUwI

Join us this Wednesday, May 21st, at 12pm EST for our next Bench2Market Talk. We'll sit down with @DCVCBio, @FlagshipPioneer, and @Emory Investment Management to discuss securing funding for your early-stage startup. Register Now:

Join us this Wednesday, May 21st, at 12pm EST for our next Bench2Market Talk. We'll sit down with @Emory Investment Management, @DCVCBio, and @FlagshipPioneer to discuss securing funding for your early-stage startup. Register Now:

We are proud to announce April's Bench2Market speaker is @gracepowers of Powers Regulatory Consulting. This session is designed for entrepreneurs new to medical device regulatory affairs. Register today! https://t.co/w9sGoJfii6

Are you preparing your next pitch for your company? Check out the recording of our latest Bench2Market Talk, "Building a Compelling Pitch - ABCs of Early-Stage Business Planning."  https://t.co/PvrKDvgGzc

We're thrilled to spotlight our portfolio team, BRIJJIT! 👨‍🔬PI: Monte Eaves, MD (Emory) 💡Wound closure technology to reduce formation of scars.

🎆✨ Happy New Year!🎆✨  Here's to a year of breakthroughs, innovation, and progress in biotechnology. May 2025 bring exciting discoveries, meaningful advancements, and endless opportunities to make a difference in the world! 🧬🥂

We're thrilled to spotlight our portfolio team, TriLEN! 👨‍🔬PI: Murali Padala, PhD (Emory) 💡A modified leaflet implant that can be sized for pediatric patients to repair tricuspid or atrioventricular valve regurgitation.

✨🎄Wishing you a joyous holiday season filled with warmth, happiness, and scientific inspiration. May this Christmas bring you moments of reflection, progress, and new opportunities for discovery. Happy holidays and best wishes for the year ahead! 🎄✨

We're thrilled to spotlight our portfolio team, Periurethral Bulking! 👨‍🔬PI: Niall Galloway, MD (Emory) 💡Device for standardizing bulking material delivery for the treatment of urinary incontinence.

We're thrilled to spotlight our portfolio team, Urearetics! 👨‍🔬PI: Jeff Sands, MD (Emory) 💡A novel mechanism to treat uremic pericarditis and pericardial effusions in chronic kidney disease patients by inhibiting urea transport.

✨ Universal Health Coverage Day✨ Universal Health Coverage Day rallies support for health for all, marking the UN's 2012 endorsement of universal health coverage. If this topic resonates with your research, apply to the Biolocity Funding cycle at https://t.co/G7Rx3dtwMa!

We're thrilled to spotlight our portfolio team, TPAM siRNA! 👨‍🔬PI: Hanjoong Jo, PhD (Emory) 💡siRNA therapeutic to stop the progression, and potentially even regress, atherosclerotic plaque formation.